The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,614.00
Bid: 2,620.00
Ask: 2,622.00
Change: -22.00 (-0.83%)
Spread: 2.00 (0.076%)
Open: 2,640.00
High: 2,644.00
Low: 2,614.00
Prev. Close: 2,636.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

8 May 2018 10:01

RNS Number : 3487N
Coca-Cola HBC AG
08 May 2018
 

 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Announcement of the annual general meeting to be held on 11 June 2018

 

Zug, Switzerland - 8 May 2018 - The Board of Directors of Coca-Cola HBC AG ("Coca-Cola HBC") has resolved to convene the Annual General Meeting ("AGM") to be held on Monday, 11 June 2018 at 11:00 am CET, at Theater Casino Zug, Artherstrasse 2-4, 6300 Zug, Switzerland.

The Board of Directors proposes to elect Mr. Zoran Bogdanovic as a member of the Board of Directors to succeed Mr. Dimitris Lois, who unfortunately passed away on 2 October 2017. Further details of the appointment of Mr. Bogdanovic as the Chief Executive Officer were announced on 7 December 2017.

The AGM will also resolve on the proposed dividend of EUR 0.54 on each ordinary registered share of Coca-Cola HBC AG with a par value of CHF 6.70 out of the general capital contribution reserve, as shown in the stand-alone financial statements (capped at an amount of CHF 300,000,000), which was initially announced on 14 February 2018, with further details announced separately today.

Furthermore, the Board of Directors proposes to approve a share buy-back of up to 7,500,000 Coca-Cola HBC ordinary shares in order to (i) avoid dilution resulting from the issuance of stock options and (ii) meet the requirements of the Coca-Cola HBC employee incentive scheme.

In addition, the Board of Directors proposes to amend the articles of association of Coca- Cola HBC in respect of management incentive and long-term incentive arrangements.

The AGM agenda items are set out in the summary below.

Agenda of the AGM

In summary, the AGM will have the following agenda and will include the following proposals by the Board of Directors:

1. Receipt of the 2017 Integrated Annual Report, as well as approval of the annual management report, the stand-alone financial statements and the consolidated financial statements

2. Appropriation of available earnings and reserves / declaration of dividend

2.1 Appropriation of available earnings

2.2 Declaration of a dividend from reserves

3. Discharge of the members of the Board of Directors and the members of the Operating Committee

4. Election of the Board of Directors, the Chairman of the Board of Directors and the Remuneration Committee

4.1 Current members of the Board of Directors

4.1.1 Re-election of Anastassis G. David as a member of the Board of Directors and as the Chairman of the Board of Directors (in a single vote)

4.1.2 Re-election of Alexandra Papalexopoulou as a member of the Board of Directors and as a member of the Remuneration Committee (in a single vote)

4.1.3 Re-election of Reto Francioni as a member of the Board of Directors and as a member of the Remuneration Committee (in a single vote)

4.1.4 Re-election of Charlotte J. Boyle as a member of the Board of Directors and as a member of the Remuneration Committee (in a single vote)

4.1.5 Re-election of Ahmet C. Bozer as a member of the Board of Directors

4.1.6 Re-election of Olusola (Sola) David-Borha as a member of the Board of Directors

4.1.7 Re-election of William W. Douglas III as a member of the Board of Directors

4.1.8 Re-election of Anastasios I. Leventis as a member of the Board of Directors

4.1.9 Re-election of Christodoulos Leventis as a member of the Board of Directors

4.1.10 Re-election of José Octavio Reyes as a member of the Board of Directors

4.1.11 Re-election of Robert Ryan Rudolph as a member of the Board of Directors

4.1.12 Re-election of John P. Sechi as a member of the Board of Directors

4.2 Election of Zoran Bogdanovic as a member of the Board of Directors

5. Election of the independent proxy

6. Election of the auditors

6.1 Re-election of the statutory auditor

6.2 Advisory vote on re-appointment of the independent registered public accounting firm for UK purposes

7. Advisory vote on the UK Remuneration Report

8. Advisory vote on the Remuneration Policy

9. Advisory vote on the Swiss Remuneration Report

10. Approval of the remuneration of the Board of Directors and the Operating Committee

10.1 Approval of the maximum aggregate amount of remuneration for the Board of Directors until the next annual general meeting

10.2 Approval of the maximum aggregate amount of remuneration for the Operating Committee for the next financial year

11. Amendments to the Articles of Association in respect of management incentive and long-term incentive arrangements

12. Approval of share buy-back

The formal notice of the AGM, including a full description of the items of the agenda and the proposals of the Board of Directors, has been published today in the Swiss Official Gazette of Commerce (Schweizerisches Handelsamtsblatt). A circular incorporating the formal notice of the AGM is sent to all registered shareholders. It has also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM, as well as on Coca-Cola HBC's website at http://coca-colahellenic.com/en/media/news/, together with the 2017 integrated annual report and other relevant shareholder information.

Zug, 8 May 2017

Coca-Cola HBC AG

The Board of Directors

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231

 basak.kotler@cchellenic.com

Joanna Kennedy

Investor Relations Manager

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Vasso Aliferi

Investor Relations Manager

Tel: +41 44 835 9274

 vasso.aliferi@cchellenic.com

 

International media contact:

Teneo Blue Rubicon

Rob Morgan

Anushka Mathew

Tel: +44 20 7260 2700 robert.morgan@teneobluerubicon.com anushka.mathew@teneobluerubicon.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 600 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAEAPSPESNPEEF
Date   Source Headline
31st Mar 202312:22 pmRNSDirector/PDMR Shareholding
31st Mar 20239:11 amRNSDirector/PDMR Shareholding
31st Mar 20238:52 amRNSDirector/PDMR Shareholding
24th Mar 20231:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:10 pmRNSDirector/PDMR Shareholding
21st Mar 20239:48 amRNSDirector/PDMR Shareholding
21st Mar 20239:20 amRNSDirector/PDMR Shareholding
20th Mar 20234:11 pmRNSAnnual Financial Report
17th Mar 20232:39 pmRNSDirector/PDMR Shareholding
15th Mar 20232:38 pmRNSDirector/PDMR Shareholding
8th Mar 202310:46 amRNSHolding(s) in Company
7th Mar 202311:56 amRNSHolding(s) in Company
6th Mar 20233:29 pmRNSDirector/PDMR Shareholding
3rd Mar 20238:00 amRNSDirector/PDMR Shareholding
1st Mar 20232:11 pmRNSIssue of equity and total voting rights
28th Feb 20238:09 amRNSDirector/PDMR Shareholding
23rd Feb 20239:21 amRNSDirector/PDMR Shareholding
22nd Feb 20233:54 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:43 pmRNSDirector/PDMR Shareholding
20th Feb 20232:46 pmRNSDirector/PDMR Shareholding
20th Feb 20232:13 pmRNSDirector/PDMR Shareholding
16th Feb 202311:28 amRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSStrong execution drives another year of growth
1st Feb 20231:50 pmRNSIssue of equity and total voting rights
18th Jan 20232:47 pmRNSDirector/PDMR Shareholding
17th Jan 20239:34 amRNSNotice of Results
5th Jan 202310:14 amRNSAthens Exchange trading date of ordinary shares
4th Jan 20233:02 pmRNSDirector/PDMR Shareholding
20th Dec 202210:16 amRNSPost 2022 AGM Shareholder Engagement
19th Dec 20223:03 pmRNSDirector/PDMR Shareholding
1st Dec 20227:44 amRNSIssue of equity and total voting rights
18th Nov 20223:13 pmRNSDirector/PDMR Shareholding
17th Nov 20228:41 amRNSDirector/PDMR Shareholding
16th Nov 20225:06 pmRNSDirector/PDMR Shareholding
14th Nov 20222:36 pmRNSDirector/PDMR Shareholding
11th Nov 20221:32 pmRNSDirector/PDMR Shareholding
11th Nov 20221:24 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSContinued positive momentum
1st Nov 20222:50 pmRNSBlock listing Interim Review
18th Oct 20223:05 pmRNSDirector/PDMR Shareholding
13th Oct 202210:40 amRNSNotice of Results
3rd Oct 202210:03 amRNSIssue of equity and total voting rights
28th Sep 20221:28 pmRNSDirector/PDMR Shareholding
21st Sep 20225:07 pmRNSIssue of Debt
20th Sep 202211:51 amRNSDirector/PDMR Shareholding
16th Sep 202212:32 pmRNS2022 Performance Share Plan Awards
15th Sep 20225:21 pmRNSIssue of Debt
15th Sep 20222:44 pmRNSHolding(s) in Company
15th Sep 20228:49 amRNSIssue of Debt
13th Sep 202212:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.